Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Trading Statement

1 Apr 2009 08:10

RNS Number : 8916P
ViaLogy PLC
01 April 2009
 



VIALOGY PLC ("VIALOGY" OR "THE COMPANY") 

VIALOGY INCREASES STAKE IN SUCCESSFUL WELL

LONDONApril 1st, 2009 - ViaLogy PLC (LSE: VIY). ViaLogy announces that it has exercised an option with Atascosa Exploration LLC, of San Antonio, Texas ("Atascosa") to acquire an increased shareholding in the Galba Prospect oil well in South Central Texas ("Cindy Bartlett #2") found in March 2009 using its QuantumRD technology. ViaLogy now owns a 10% direct working interest in the Cindy Bartlett #2 well with revenue to ViaLogy expected to begin in Q2 this year. This means that ViaLogy will receive 10% of the Net Revenue Interest of the well over its lifespan. The amount of oil in the well has been calculated using industry standard core analysis practices.

 

ViaLogy has also agreed terms and dates with Atascosa for the near-term drilling of a second well on the Galba Prospect in south central Texas. Using ViaLogy's patented QuantumRD technology, the Company's scientists and Atascosa's geology and engineering team will immediately examine 3D seismic data and QuantumRD analysis to decide the optimum location position for the drilling rig. Spudding of the second well is expected to start within weeks.

ViaLogy's increased holding in Cindy Bartlett #2, and the drilling of the new well, to be called Cindy Bartlett #3, further cements the relationship with Atascosa following the success of QuantumRD which was announced on 23 March 2009 on the discovery of a series of three new oil formations at increasing depths on the Galba Prospect. The first well on the site, Cindy Bartlett #2, was drilled into the formation lying at 3,100 feet. Use of the QuantumRD seismic interpretation technology verifies the presence of hydrocarbons, permits characterization of the reservoir and porosity, and siting of the drill location. The technology is based on protected active signal processing software capable of exploiting the "noise" inherent in most seismic data. 

 

"For the immediate future we are focussing our activities on Texas," said ViaLogy's Chief Executive, Robert W. Dean. "We have a new technology that is proving its ability to improve the ratio of producing successful wells instead of dry holes, which for on-shore drilling in the continental USA currently occur in six cases out of ten. But the real secret is to combine our value-added ability to more effectively interpret the seismic data with the experience of geologists and oil men who know the areain which we work." 

"In this regard, over the past six months we've developed an excellent working relationship with Atascosa Exploration, and both companies have agreed to work closely together on future projects. So we welcomed the opportunity when Atascosa offered us a larger participation in the successful well we'd developed together."

 

Ends

 

For further information please contact:

ViaLogy

Robert W Dean, President & CEO - US +1 626-296-6337 (mobile: +1 703-589-3807) Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734 (mobile: 07860 842756)

Atascosa Exploration LLC   John D. Mullins, CEO (+1 210-402-3656) 

Nominated Advisor to ViaLogy PLC (Seymour Pierce)   Mark Percy +44 (0) 20-7107-8000

Broker to ViaLogy PLC (St. Helen's Capital)

Ruari McGirr / Sebastian Wykeham +44 (0) 207 628 5582 

 

About ViaLogy: 

ViaLogy is a leading innovator of network-centric, real-time signal processing platforms for sensor applications. ViaLogy is currently deploying and designing computational systems, powered by its patented technologies, for applications in life sciences, public safety and security, surveillance, defense and geoseismology. ViaLogy focuses on market driven problems where automation, timeliness, quality and reliability of information processing are essential. ViaLogy's core competency incorporates rapidly and accurately detecting weak signals buried in high noise background and clutter. This technology can be employed to solve problems involving sensor integration and information overload challenges involving video, telephony and control sensors, as well as for enhancement of numerous signal processing applications. For more information, visit our website at www.ViaLogy.com

Except for statements of historical fact, the information presented herein constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUUUMUCUPBUMG
Date   Source Headline
30th Nov 201511:20 amRNSNotice of Results
12th Nov 20157:00 amRNSPositive independent study results for IONA test
28th Oct 20157:00 amRNSAppointment to the Board
15th Oct 20153:56 pmRNSWorld first: in-house antenatal reflex screening
14th Oct 20157:00 amRNSClinical laboratory with expanded capacity opened
14th Oct 20157:00 amRNSHolding(s) in Company
13th Oct 20154:08 pmRNSResult of AGM
13th Oct 20152:20 pmRNSHolding(s) in Company
13th Oct 20157:01 amRNSAGM Statement
13th Oct 20157:00 amRNSPremaitha collaborates with Wolfson screening lab
12th Oct 20157:00 amRNSIndependent study of the IONA® test published
2nd Oct 20157:00 amRNSPremaitha appoints Greek distributor
1st Oct 20154:14 pmRNSPatent Infringement Proceedings Update
22nd Sep 20157:00 amRNSFinal Results
22nd Sep 20157:00 amRNSPremaitha signs contract for IONA test in Chile
15th Jul 20157:00 amRNSGrant of Options
13th Jul 20152:04 pmRNSHolding(s) in Company
6th Jul 20157:00 amRNSCQC accreditation for new NIPT lab
2nd Jul 20152:59 pmRNSCompletion of placing to raise £8 million
2nd Jul 20157:00 amRNSProposed placing to raise approximately £8 million
24th Jun 20157:00 amRNSNew IONA test clinical data showcased
22nd Jun 20157:00 amRNSNew contract for IONA® test
19th Jun 20157:00 amRNSTrading Update
4th Jun 20157:00 amRNSAppointment of Chief Financial Officer
5th May 20157:01 amRNSPremaitha Files Robust Defence with UK High Court
29th Apr 20151:53 pmRNSReissue of Options
31st Mar 20157:00 amRNSNew Contract for IONA test in Poland
23rd Mar 20159:53 amRNSLondon NHS trust teams up with Premaitha Health
16th Mar 20159:40 amRNSNotice of Patent Infringement Proceedings
16th Mar 20157:00 amRNSPremaitha Health signs first NIPT agreement
5th Feb 20157:00 amRNSCE Mark and Launch of the IONA test
30th Jan 20157:00 amRNSCommercial Launch Preparation Update
10th Dec 20147:00 amRNSResults for 7 months to 30 September 2014
25th Nov 20147:00 amRNSNotice of Half Year Results and IONA Test Showcase
4th Nov 201412:07 pmRNSResult of AGM
4th Nov 20147:00 amRNSAGM Statement
2nd Oct 20147:00 amRNSGrant of Options
30th Sep 20147:00 amRNSPublication of Annual Report and Notice of AGM
7th Jul 20144:47 pmRNSHolding(s) in Company
4th Jul 20144:28 pmRNSHolding(s) in Company
4th Jul 20147:00 amRNSFirst Day of Dealings on AIM
3rd Jul 20143:42 pmRNSChange of Name
3rd Jul 201411:36 amRNSResult of EGM
1st Jul 201410:47 amRNSOpen Offer Oversubcribed
13th Jun 20147:30 amRNSSchedule 1 - ViaLogy Plc
13th Jun 20147:30 amRNSRestoration - ViaLogy Plc
13th Jun 20147:00 amRNSPublication of Admission Document & Lifting of...
13th Jun 20147:00 amRNSDirectorate Change
13th Jun 20147:00 amRNSFinal Results
15th Apr 201412:30 pmRNSSuspension - Vialogy plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.